Boston Scientific Corporation Stock

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-05-10 pm EDT 5-day change 1st Jan Change
73.69 USD -0.55% Intraday chart for Boston Scientific Corporation +1.15% +27.47%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 15.98B Sales 2025 * 17.55B Capitalization 108B
Net income 2024 * 2.19B Net income 2025 * 2.72B EV / Sales 2024 * 7.16 x
Net Debt 2024 * 6.06B Net Debt 2025 * 3.7B EV / Sales 2025 * 6.38 x
P/E ratio 2024 *
50.3 x
P/E ratio 2025 *
40.8 x
Employees 48,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.65%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.55%
1 week+1.15%
Current month+2.53%
1 month+7.34%
3 months+12.50%
6 months+42.92%
Current year+27.47%
More quotes
1 week
72.42
Extreme 72.42
74.30
1 month
66.80
Extreme 66.8
74.39
Current year
57.11
Extreme 57.11
74.39
1 year
48.35
Extreme 48.35
74.39
3 years
34.98
Extreme 34.98
74.39
5 years
24.10
Extreme 24.1
74.39
10 years
11.10
Extreme 11.1
74.39
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 11-10-16
Director of Finance/CFO 58 96-11-30
Chief Tech/Sci/R&D Officer - 09-08-31
Members of the board TitleAgeSince
Director/Board Member 71 16-07-12
Director/Board Member 61 21-06-22
Director/Board Member 69 15-03-31
More insiders
Date Price Change Volume
24-05-10 73.69 -0.55% 3,790,579
24-05-09 74.1 +1.90% 6,134,777
24-05-08 72.72 -0.97% 5,054,088
24-05-07 73.43 +1.21% 4,151,544
24-05-06 72.55 -0.41% 4,922,960

Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT

More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
73.69 USD
Average target price
81.16 USD
Spread / Average Target
+10.14%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW